| 000 | 01631 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515171128.0 | ||
| 264 | 0 | _c20091009 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1098-2396 | ||
| 024 | 7 |
_a10.1002/syn.20652 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Jinbin | |
| 245 | 0 | 0 |
_a[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization. _h[electronic resource] |
| 260 |
_bSynapse (New York, N.Y.) _cSep 2009 |
||
| 300 |
_a717-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Agents _xmetabolism |
| 650 | 0 | 4 |
_aDrug Interactions _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aPharmacokinetics |
| 650 | 0 | 4 |
_aPiperazines _xchemistry |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Dopamine D3 _xdrug effects |
| 650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
| 650 | 0 | 4 |
_aTritium _xmetabolism |
| 700 | 1 | _aChu, Wenhua | |
| 700 | 1 | _aTu, Zhude | |
| 700 | 1 | _aJones, Lynne A | |
| 700 | 1 | _aLuedtke, Robert R | |
| 700 | 1 | _aPerlmutter, Joel S | |
| 700 | 1 | _aMintun, Mark A | |
| 700 | 1 | _aMach, Robert H | |
| 773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 63 _gno. 9 _gp. 717-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/syn.20652 _zAvailable from publisher's website |
| 999 |
_c18853411 _d18853411 |
||